Press Releases

Theatre Alliance of Buffalo Launches 2016 Applause for Hope Program to Support Roswell Park

The Theatre Alliance of Buffalo (TAB) has launched its 2016 Applause for Hope program, a collaborative fundraising initiative that supports both Roswell Park Comprehensive Cancer Center and TAB. From mid-January to mid-March, a majority of TAB member theaters will be collecting post-performance donations.

Tuesday, February 2, 2016 - 07:00 am

News

The Ride For Roswell Launches Registration for 2016 Event on June 24 and 25

BUFFALO, N.Y. — The Ride For Roswell, presented by West Herr Automotive Group, has launched registration for its 2016 event on June 24 and 25.

Monday, February 1, 2016 - 07:00 am

News

Users of Cherry-Flavored E-Cigarettes May Be Exposed to Higher Levels of Respiratory Irritant

BUFFALO, N.Y. — An analysis of 145 different electronic-cigarette flavoring products reveals that many e-cigarette users may be exposed to a potentially harmful chemical.

Friday, January 29, 2016 - 07:00 am

News

Leading American Cancer Centers Endorse HPV Vaccination for Cancer Prevention

Roswell Park Cancer Institute has joined with all the top cancer centers across the nation in issuing a statement urging for increased HPV vaccination for the prevention of cancer. Recognizing that insufficient vaccination is a public health threat, these leading institutions have called upon the nation’s physicians, parents and young adults to take advantage of this rare opportunity to prevent many types of cancer.

Wednesday, January 27, 2016 - 07:00 am

News

Study Identifies New Class of Anticancer Compounds for Possible Targeted Therapy in Blood Cancers

A research team from the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute (RPCI) has discovered a new class of small-molecule compounds that are good candidates for development of novel targeted therapies in the treatment of leukemia and lymphoma.

Tuesday, January 26, 2016 - 07:00 am

News

Roswell Park Scientists Contribute to Understanding of Novel Class of Cancer-Targeting Agents

Researchers in the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute (RPCI) offer greater clarity of how a novel class of cancer-targeting agents called BET (Bromodomain and Extra-Terminal) inhibitors stimulate cell death in laboratory models of human cancers, specifically B-cell lymphomas.

Thursday, January 21, 2016 - 07:00 am

News

Four Buffalo Sabres to Shave Their Heads for Roswell Park's Bald for Bucks

The Buffalo Sabres today announced three current players and one alumnus will shave their heads on Saturday, Feb. 20 as part of the Bald for Bucks program, which raises money for Roswell Park Comprehensive Cancer Center.

Tuesday, January 19, 2016 - 07:00 am

News

Roswell Park Investigators Evaluate Enzyme Inhibitor for Rare Lymphoma

Roswell Park Cancer Institute (RPCI) scientists report a novel enzyme inhibitor, Pevonedistat, demonstrated effectiveness in the laboratory against Mantle Cell Lymphoma (MCL), a rare and aggressive subtype of non-Hodgkin Lymphoma.

Monday, January 11, 2016 - 07:00 am

News

29 Roswell Park Physicians Listed America’s Top Doctors®

Twenty-nine physicians from Roswell Park Cancer Institute (RPCI) are included in the Castle Connolly Medical, Ltd. prestigious America’s Top Doctors® list.

Monday, December 28, 2015 - 07:00 am